
词语导航
基本信息
词语:蛋白尿的
繁体:蛋白尿的
拼音:dàn bái niào de
英语翻译
【医】 albuminuretic; albuminuric; proteinuric; proteuric
分词翻译
蛋的英语翻译:
egg【医】 oo-; ovi; ovi-; ovo
白尿的英语翻译:
【医】 albiduria; albinuria翻译例句
1. 对直立性蛋白尿的发病进行了讨论。
The pathogenesis of orthostatic proteinuria was discussed.
2. 丰富了蛋白尿的治疗思路。
It enriches the thoughts for the treatment of renal albuminuria.
3. 目的:观察黄芪对肾性蛋白尿的治疗作用。
Objective: To investigate the effect of Radix Astragali in treating proteinuria in patients with chronic glomerulonephritis (CGN).
4. 蛋白尿的程度与肾脏和心血管事件相关(1)。
Degree of proteinuria is associated with risk of renal and cardiovascular events (1).
5. 结论:益肾液是治疗肾小球蛋白尿的有效制剂。
Conclusion: Yishen Fluid is effective pharmaceutics in treating glomerulus albuminuria.
6. 这种相关性很大程度上不依赖于蛋白尿的水平。
This association is largely independent of the level of albuminuria.
7. 目的:观察益肾液治疗肾小球性蛋白尿的疗效。
Objective: To observe the therapeutic effect on glomerulus albuminuria treated by Yishen Fluid.
8. 对20例单纯性蛋白尿的临床和病理资料进行分析。
The clinical and pathologic data of 20 children with simple proteinuria were analyzed.
9. 目的:运用琼脂糖凝胶区带电泳进行蛋白尿的分析。
To study proteinuria with agarose gel zone electrophoresis.
10. 目的观察鲤鱼汤对阿霉素肾病大鼠蛋白尿的治疗作用。
ObjectiveTo observe the therapeutic effect of Cyprinus carpio decoction on proteinuria of adriamycin nephrosis rats.
11. 接受更高剂量的贝伐单抗的患者有更大的患蛋白尿的风险。
Patients taking higher dosages of bevacizumab had the greatest risk of developing proteinuria.
12. 目的:观察伊贝沙坦对良性小动脉性肾硬化蛋白尿的效应。
Objective: To observe the effect of irbesartan on proteinuria in benign arteriolar nephrosclerosis patients.
13. 接受更高剂量的贝伐单抗的患者有更大的患蛋白尿的风险。
Patients taking higher dosages of bevacizumab had the greatest risk of developing proteinuria .
14. 结论微量白蛋白尿的测定可用于监测、防治糖尿病性心脏病。
Conclusions The menstruations of micro albumin urine can be applied to the prevention of diabetic heart disease.
15. 旨在降低蛋白尿的治疗是否同样可以减少心血管疾病的风险?
Can treatment aimed at reducing albuminuria lead to cardiovascular risk reduction as well?
16. 目的:观察肾舒胶囊配合激素等西药治疗重度肾性蛋白尿的效果。
Objective: To observe the effect of Shenshu capsule match hormone in the treatment of heavy kidney albuminuria.
17. Kappa统计利用临床相关的蛋白尿的分类评估两种方法的一致性。wWW.wEntiyi.com
Kappa statistic was employed to evaluate concordance between the two methods taking into account clinically relevant categories of proteinuria.
18. 根据我们的资料,我们猜测体重变化引起的血管炎能引起蛋白尿的变化。
Based on our data we hypothesize that weight-induced changes in vascular inflammation may cause changes in albuminuria.
19. 在一般人群中,体重变化对蛋白尿的影响及可能的作用机制尚未被研究。
The impact of weight change on albuminuria and its possible mechanism has not been studied yet in the general population.
20. 目的基于文献探讨慢性肾小球肾炎(CGN)蛋白尿的中医用药规律。
Objective To explore the rule of Chinese medicine in treating chronic glomerulonephritis (CGN) proteinuria on the base of literature.
21. 同样,肾脏并发症通常是由蛋白尿的进展、终末期肾病、以及死亡来预示。
Likewise, in renal complications, usually heralded by the development of protein urea and end-stage renal disease, and mortality also.
22. 目的观察血管紧张素转换酶抑制剂苯那普利减轻幼龄肾病大鼠蛋白尿的作用。
Objective To observe the effect of benazepril, an angiotensin converting enzyme inhibitor (ACEI) , on reducing proteinuria in a nephrotic young rat model of with massive proteinuria.
23. 结论HPA在糖尿病肾病中的表达升高可能参与了糖尿病肾病蛋白尿的发生。
Conclusion the increased expression of HPA maybe participate in the pathogenesis of proteinuria in DN.
24. 目的观察低分子肝素联合血管转换酶抑制剂对糖尿病肾病显性蛋白尿的治疗效果。
Objective To investigate the effects of the combination of low molecular weight heparin and ACEI on albuminuria in diabetic nephropathy.
25. 目的探讨中药益肾固精方对大鼠早期糖尿病肾病(DN)蛋白尿的防治及可能机制。
Objective To study the mechanism of preventing proteinuria by traditional Chinese medicine YSGJD in early diabetic nephropathy (DN) in rats.
26. 白蛋白是糖尿病早期肾脏病变的特征,在最初的人类实验中已经报道了白蛋白尿的减少。
Reductions in albuminuria, a hallmark of early diabetic kidney disease, have been reported in initial human trials.
27. 结果表明(1)运动性蛋白尿的排泄量主要取决于运动强度,与运动持续时间关系不大;
Results showed as follows, (1) The rate of protein excretion was related to the intensity of exercise rather than to its duration;
28. 目的:探讨洛丁新治疗小儿肾性蛋白尿的效果、安全性以及与ace基因多态性的相互关系。
Objective: to explore the effect and safety of Lotensin in the treatment of childrens renal proteinuria and its relation to ACE gene.
29. 目的:研究急性脑梗死患者微量白蛋白尿的发生率、与脑卒中危险因素及脑梗死复发的关系。
OBJECTIVE: to investigate the relationship between the incidence of MAU in patients with acute cerebral infarction and the risk factor of stroke and the recurrence of cerebral infarction.
30. 对不同肿瘤类型的患者进行研究发现,患有肾癌的病人发生蛋白尿的风险最高,为10.2%。
Also, when the investigators looked at differences by cancer type, they found that patients with kidney cancer had the highest risk of developing proteinuria (10.2% incidence).
版权声明:问题易所有作品(图文、音视频)均来源网络,版权归原创作者所有,与本站立场无关,如不慎侵犯了你的权益,请联系我们告知,我们将做删除处理!
